HKPD

CELLYAN BIOTECHNOLOGY CO LTD

HKPD·G6365B104·US·Common Stock·Healthcare - Pharmaceutical Retailers-Activist

HKPD (CELLYAN BIOTECHNOLOGY CO LTD) is held by 3 institutional investors as of Q1 2026. Largest holders: Clear Street Group Inc. ($6,833), TWO SIGMA INVESTMENTS, LP ($6,158), UBS Group AG ($63). Net institutional sentiment: Bearish.

3
Holders
$13,054
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress:
HKPDSmart Money Verdict
View all
Held by 3 funds
Who's Trading
ActivistLWLiying Wang65.0%Nov 12, 2025
ActivistAHAtlantic Health Century International Group5.6%Jun 5, 2025
ActivistPHPacific Health Century International Group5.6%Jun 5, 2025
ActivistLSLap Sun Wong56.8%Jun 3, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
12,019$6,8330.0%-72.05%
0
Decreased
10,832(-35.3%)$6,1580.0%-45.12%
0
Decreased
110(-92.8%)$630.0%-47.56%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used